Hong Xiang Zuo Selected Research

convallatoxin

1/2022	Convallatoxin inhibits IL-1β production by suppressing zinc finger protein 91 (ZFP91)-mediated pro-IL-1β ubiquitination and caspase-8 inflammasome activity.
3/2020	Convallatoxin promotes apoptosis and inhibits proliferation and angiogenesis through crosstalk between JAK2/STAT3 (T705) and mTOR/STAT3 (S727) signaling pathways in colorectal cancer.
1/2019	Convallatoxin protects against dextran sulfate sodium-induced experimental colitis in mice by inhibiting NF-κB signaling through activation of PPARγ.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hong Xiang Zuo Research Topics

Disease

10	Neoplasms (Cancer) 01/2022 - 05/2017
6	Hypoxia (Hypoxemia) 07/2020 - 05/2017
3	Colitis 01/2022 - 01/2019
3	Inflammation (Inflammations) 01/2022 - 01/2018
3	Uterine Cervical Neoplasms (Cancer of the Cervix) 01/2022 - 06/2021
3	Colonic Neoplasms (Colon Cancer) 01/2020 - 05/2017
2	Peritonitis 01/2022 - 01/2022
2	Carcinogenesis 01/2022 - 01/2018
2	Neoplasm Metastasis (Metastasis) 07/2020 - 03/2020
1	Hepatocellular Carcinoma (Hepatoma) 01/2021
1	Liver Neoplasms (Liver Cancer) 07/2020
1	Colorectal Neoplasms (Colorectal Cancer) 03/2020
1	Ulcerative Colitis 01/2019
1	Migraine Disorders (Migraine) 05/2017
1	Toothache (Toothaches) 05/2017

Drug/Important Bio-Agent (IBA)

4	Proteins (Proteins, Gene)FDA Link 01/2022 - 05/2017
4	LigandsIBA 01/2021 - 01/2018
3	convallatoxinIBA 01/2022 - 01/2019
3	matrigelIBA 01/2021 - 07/2020
2	aluminum sulfate (alum)IBA 01/2022 - 01/2022
2	panaxadiolIBA 01/2022 - 01/2020
2	Drinking WaterIBA 01/2022 - 01/2022
2	Dextran SulfateIBA 01/2022 - 01/2019
2	B7-H1 AntigenIBA 07/2021 - 01/2021
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2021 - 03/2020
2	70-kDa Ribosomal Protein S6 Kinases (Ribosomal Protein S6 Kinases, 70 kDa)IBA 07/2020 - 05/2017
2	Pharmaceutical PreparationsIBA 07/2020 - 08/2017
2	Transcription Factors (Transcription Factor)IBA 01/2019 - 08/2017
1	InflammasomesIBA 01/2022
1	Caspase 8 (Caspase-8)IBA 01/2022
1	formononetinIBA 01/2022
1	Blood Glucose (Blood Sugar)IBA 01/2022
1	Biological ProductsIBA 01/2022
1	Immune Checkpoint InhibitorsIBA 07/2021
1	usnic acidIBA 07/2021
1	ErianinIBA 06/2021
1	britanninIBA 01/2021
1	carrimycinIBA 01/2021
1	curcumolIBA 07/2020
1	Volatile Oils (Essential Oils)IBA 07/2020
1	Eukaryotic Initiation Factor-4EIBA 07/2020
1	STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA 07/2020
1	SurvivinIBA 03/2020
1	Cyclin D1IBA 03/2020
1	Phosphatidylinositols (Phosphatidylinositol)IBA 01/2020
1	Mitogen-Activated Protein KinasesIBA 01/2020
1	CytokinesIBA 01/2019
1	Dextrans (Dextran)FDA Link 01/2019
1	sodium sulfate (sodium bisulfate)FDA LinkGeneric 01/2019
1	dictamnineIBA 12/2018
1	OccludinIBA 12/2018
1	Cadherins (E-Cadherin)IBA 12/2018
1	VimentinIBA 12/2018
1	fraxinelloneIBA 01/2018
1	chelidonineIBA 01/2018
1	Reactive Oxygen Species (Oxygen Radicals)IBA 08/2017
1	shikoninIBA 08/2017
1	trioctyl phosphine oxide (TOPO)IBA 05/2017
1	Type I DNA Topoisomerases (Topoisomerase I)IBA 05/2017
1	imperatorinIBA 05/2017
1	Furocoumarins (Furanocoumarins)IBA 05/2017

Therapy/Procedure

4	Therapeutics 01/2021 - 08/2017
3	Chinese Traditional Medicine (Traditional Chinese Medicine) 01/2022 - 05/2017
2	Oral Administration 01/2022 - 01/2022
2	Intraperitoneal Injections 01/2022 - 01/2022
2	Immunotherapy 06/2021 - 07/2020
1	Aftercare (After-Treatment) 01/2021